Vicarious Surgical (RBOT) Cash from Investing Activities (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Cash from Investing Activities came in at $9.7 million in Q3 2025, up 2069.92% year-on-year from $446652.7 in Q3 2024, and down 34.6% on a QoQ basis from $14.8 million in Q2 2025.
Vicarious Surgical (RBOT) Cash from Investing Activities (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Cash from Investing Activities data on file, last reported at $9.7 million in Q3 2025.
- On a quarterly basis, Cash from Investing Activities rose 2069.92% year-over-year to $9.7 million in Q3 2025; TTM through Sep 2025 was $43.6 million, a 1814.16% increase from a year earlier, with the FY2024 full-year figure at $6.9 million, up 114.99% from the prior year.
- Cash from Investing Activities for Q3 2025 stood at $9.7 million, down from $14.8 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for RBOT reached as high as $14.8 million in Q2 2025 and fell as low as -$43.8 million in Q1 2023.
- Historically, Cash from Investing Activities has averaged -$865105.3 across 5 years, with a median of -$492000.0 in 2024.
- Across the five-year window, Cash from Investing Activities sank 2067.56% in 2023 and jumped 3303.47% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at -$867000.0 in 2021, then slipped by 14.42% to -$992000.0 in 2022, then surged by 608.57% to $5.0 million in 2023, then surged by 186.42% to $14.4 million in 2024, then plunged by 32.93% to $9.7 million in 2025.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were $9.7 million in Q3 2025, $14.8 million in Q2 2025, and $4.6 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -298.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -475.32 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9.69 Mn |
| Sep 30, 2025 | 9.69 Mn |
| Jun 30, 2025 | 14.82 Mn |
| Jun 30, 2025 | 14.82 Mn |
| Mar 31, 2025 | 4.61 Mn |
| Mar 31, 2025 | 4.61 Mn |
| Dec 31, 2024 | 14.45 Mn |
| Dec 31, 2024 | 14.45 Mn |
| Sep 30, 2024 | -492,000.00 |
| Sep 30, 2024 | -492,000.00 |
| Jun 30, 2024 | -6.95 Mn |
| Jun 30, 2024 | -6.95 Mn |
| Mar 31, 2024 | -144,000.00 |
| Mar 31, 2024 | -144,000.00 |
| Dec 31, 2023 | 5.05 Mn |
| Dec 31, 2023 | 5.05 Mn |
| Sep 30, 2023 | -644,000.00 |
| Sep 30, 2023 | -644,000.00 |
| Jun 30, 2023 | -6.36 Mn |
| Jun 30, 2023 | -6.36 Mn |